J&J’s Prezista Approved For Treatment-Resistant HIV
The protease inhibitor – formerly known as TMC-114 – is to be co-administered with a low dose of ritonavir.
The protease inhibitor – formerly known as TMC-114 – is to be co-administered with a low dose of ritonavir.